data report
PreclinicalSmall molecule
data report is one of 8 small molecule programs targeting Bullous Pemphigoid. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
8 competitors in Bullous Pemphigoid
#DrugCompanyPhaseTrials
1Trexall
Jazz PharmaceuticalsApproved
Rayos
RRoxane Laboratories
Approved
Avlosulfon
AAlmirall, S.A.
Approved
Deltasone
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Imuran
LLegacy Health System
Approved
Stapokibart
CChengdu Kangnuoxing Biopharma,Inc.
Phase 3
Janus Kinase Inhibitor
PPeking Union Medical College Hospital
Preclinical
data report
AAssistance Publique Hopitaux De Marseille
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for data report. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details